BitcoinWorld Coinbase WalletConnect: A Crucial Step for Decentralized Connectivity Get ready for some exciting news in the crypto world! Coinbase, a leading cryptocurrency exchange, recently announced a significant addition to its asset roadmap: the WalletConnect Token (WCT) . This development, shared via their official X account, marks a crucial step for Coinbase WalletConnect , potentially enhancing how millions interact with the decentralized web. It signals a growing recognition of the importance of seamless, secure decentralized connectivity within the broader crypto ecosystem. What Exactly is WalletConnect Token (WCT) and Its Core Purpose? Before diving into the implications, let’s understand the core technology. WalletConnect is an open-source protocol that allows decentralized applications (dApps) to securely connect with mobile wallets. Think of it as a bridge, enabling users to interact with dApps without compromising their private keys. The WalletConnect Token (WCT) is the native cryptocurrency of the WalletConnect protocol. It plays a vital role in the ecosystem, facilitating governance, potentially enabling gasless transactions, and supporting the ongoing development of the protocol. This token is designed to empower the community and drive the future of decentralized connectivity . Why is Coinbase’s Asset Roadmap Inclusion So Significant? Coinbase adding WCT to its Coinbase asset roadmap is more than just a simple announcement; it’s a powerful endorsement. Coinbase is one of the largest and most regulated cryptocurrency exchanges globally. Its asset roadmap often acts as a strong indicator of potential future listings, bringing immense visibility and legitimacy to the projects it includes. For the WCT crypto community, this news is a game-changer. It suggests that WCT meets Coinbase’s rigorous listing standards, which consider factors like legal compliance, security, and market demand. Moreover, it opens the door for potentially millions of new users to access WCT, significantly increasing its liquidity and reach. Unlocking Enhanced Decentralized Connectivity with Coinbase WalletConnect The integration possibilities between Coinbase and WalletConnect are immense, promising a more streamlined experience for users. Here are some key benefits: Seamless dApp Interaction: Users may soon experience even smoother connections between their Coinbase Wallet and a vast array of dApps across various blockchain networks. Improved Security: WalletConnect’s secure handshake mechanism ensures that private keys remain safe within the user’s wallet, never exposed to the dApp. Broader Adoption: By making decentralized applications more accessible and user-friendly, this move can significantly accelerate the mainstream adoption of Web3 technologies. Enhanced User Experience: The focus on Coinbase WalletConnect aims to simplify complex interactions, making DeFi, NFTs, and other Web3 services approachable for a wider audience. What’s Next for WCT Crypto and the Broader DeFi Landscape? While inclusion on the Coinbase asset roadmap does not guarantee an immediate listing, it typically precedes such an event. Should WCT officially list on Coinbase, it could trigger substantial price action due to increased demand and accessibility. This development underscores Coinbase’s commitment to supporting innovative projects that enhance the utility and reach of the crypto space. The move also highlights a broader trend towards interoperability and seamless user experiences in decentralized finance. Projects like WalletConnect are crucial for breaking down barriers between different blockchain ecosystems, fostering a truly interconnected and accessible Web3. The future for WCT crypto and its role in fostering widespread decentralized connectivity looks incredibly promising. In conclusion, Coinbase’s decision to add the WalletConnect Token (WCT) to its asset roadmap is a landmark event. It not only validates the importance of WalletConnect’s protocol but also paves the way for a more integrated, secure, and user-friendly decentralized future. This strategic move by Coinbase WalletConnect could truly redefine how we engage with the evolving world of blockchain and Web3. Frequently Asked Questions (FAQs) 1. What is WalletConnect Token (WCT)? WCT is the native token of the WalletConnect protocol, an open-source standard for connecting decentralized applications (dApps) to crypto wallets securely. It supports governance and network operations. 2. What does it mean for WCT to be on Coinbase’s asset roadmap? Being on Coinbase’s asset roadmap indicates that Coinbase is exploring or has decided to support the token. It often precedes a full listing on the exchange, signaling strong potential and legitimacy. 3. Will WCT be listed on Coinbase soon? While inclusion on the roadmap is a strong indicator, it does not guarantee an immediate listing. Coinbase conducts thorough reviews, and the actual listing date depends on various factors. 4. How does WalletConnect enhance decentralized connectivity? WalletConnect provides a secure, universal way for users to connect their crypto wallets to any dApp. This eliminates the need for complex integrations and enhances the overall user experience across the decentralized web. 5. What are the benefits for Coinbase users from this development? If WCT is fully integrated, Coinbase users could benefit from more seamless, secure interactions with a wider range of dApps, improving their overall experience within the decentralized ecosystem. Did you find this article insightful? Help us spread the word about this significant development! Share this article on your social media channels and let your network know about the exciting future of Coinbase WalletConnect and decentralized finance. To learn more about the latest crypto market trends, explore our article on key developments shaping WalletConnect institutional adoption. This post Coinbase WalletConnect: A Crucial Step for Decentralized Connectivity first appeared on BitcoinWorld and is written by Editorial Team
Bitcoin’s network activity is on the rise, with 94% of its supply in profit. While short-term traders are taking profits, long-term holders are accumulating, indicating strong market confidence. 94% of
Summary 180 Life Sciences Corp. has pivoted from a biotech to an Ethereum treasury, driving a massive stock price surge and a rebrand to ETHZilla. The company raised $425M via PIPE and $156M in convertible notes, using proceeds primarily to acquire ETH, now holding over 82,000 ETH. Peter Thiel's rumored 7.5% stake and a new on-chain yield strategy with Electric Capital have fueled investor enthusiasm and rapid valuation growth. I can think of two other struggling biotechs that have pivoted into cryptocurrency, offering fast access to capital markets and potentially outsized shareholder returns. The share price of 180 Life Science Corp is up >145% in trading today, priced at $7.7 at the time of writing, but these gains have nothing to do with the one-time biotech's clinical drug development programs, and everything to do with its recent pivot into becoming an Ethereum (a type of cryptocurrency) treasury - and the apparent news that Peter Thiel has taken a stake in the company. For more information on an extraordinary and very rapid pivot, and how this is beginning to become a trend in the biotech sector, read on. 180's One-Eighty - Anatomy Of A Blockchain Pivot 180 Life Sciences Corp. ( ATNF ) is, or rather was, a struggling biotech. The last time I covered the company it was for my Investing Group subscribers in June 2022, reporting on the bad news that the FDA had rejected management's proposition to use data from a Phase 2b study to support an application for approval of adalimumab - Pharma giant AbbVie's ( ABBV ) one-time globally best-selling drug Humira - to treat Dupuytren’s Contracture. That is a common chronic, progressive fibrotic condition of the hand that causes the fingers to curl irreversibly into the palm which affects ~12m people in the U.S. At that time, 180's stock traded >$1 per share, and it had reported a cash position of ~$6m, having made a net loss of >$(20m) in 2021. In February 2023, the company's study of an intra-articular injection of anti-TNF (adalimumab) to treat frozen shoulder was closed , after only 9 patients were recruited, and in November of that year, its Board of Director's announced it intended to "consider a broad range of strategic, operational and financial alternatives." The company somehow managed to remain as a listed entity despite frequently contravening Nasdaq regulations, which requires listed issuers to maintain minimum stockholders’ equity of $2.5 million, and maintain a share price >$1, helped by a couple of reverse stock splits, and by securing an extension from Nasdaq in July 2024. In September 2024, the company appointed a new Chief Financial Officer, Omar Jimenez - according to a press release : Mr. Jimenez has significant experience in the finance and operations sector, having worked in various high-profile roles in companies such as Golden Matrix Group Inc., Alfadan, Inc., Monaker Group, Inc., Marmel International, Inc., American Leisure Holdings, Inc., US Installation Group, and Onyx Group, Inc. These companies have very little to do with biotech - a foreshadowing of what was to come, perhaps - but in November 180 announced it had regained compliance with Nasdaq listing laws. Then, in October last year, 180 stock skyrocketed to >$15 per share, albeit briefly, as the company released a statement as follows: We are excited to announce that 180 is planning to strategically enter into the online gaming industry, utilizing its newly acquired "back-end" gaming platform, which incorporates blockchain technology and full cryptocurrency operability (the "Gaming Technology Platform"). The platform would have a "blockchain casino operations back end," the press release continued, and a range of other features, including player account management, loyalty systems for blockchain users, and an affiliate tracking system. Shares quickly retreated to ~$1.8 per share, but in December 180 announced its had raised $2.49m via a registered direct offering, and that it had regained compliance with Nasdaq laws that require a company to "maintain an audit committee consisting of three independent directors." On the gaming platform front, there was seemingly no news, but in April this year, 180 announced it had "entered into a Settlement and Mutual Release Agreement with Elray Resources, and Luxor Capital," and bought back 1.32m shares for a price of $1m. Then, to bring us up to date, at the end of last month, 180 dropped its biggest bombshell yet. First, the company announced an offering of: approximately $425 million private investment in public equity transaction ("PIPE") for the purchase and sale of common stock (and pre-funded warrants, if applicable) at a purchase price of $2.65 per share. In addition, the Company has approval to sell an aggregate amount of up to $150 million in debt securities and expects to announce an offering following the closing of the PIPE. What would the funds be used for? Upon closing, the Company intends to use the net proceeds from the offering primarily for the purchase of ETH, as well as general corporate purposes and transaction expenses. The Company's current management team and a majority of the Company's directors will remain in place. ETH means Ethereum (ETH-USD). According to McAndrew Rudisill, who the press release stated "is expected become chairman of the board of directors of the Company at closing," the cryptocurrency: has a market cap over $450 billion today, which exceeds many of the most well-known companies in the world and powers some of the major innovations taking the global financial system by storm today In fact, Ethereum has a market cap valuation of $528.3bn at the time of writing (according to TradingView ), its price having risen to $4,455, up >1,000% on a five year basis, and up 75% on a 12-month basis, and >60% across the past six months (at the time of writing, it is up >5% in trading today). What Happened To 180's Drug Development Pipeline? & The Casino? Good question. According to 180's Q2 2025 quarterly report / 10Q filing , which was released on 23rd July: We currently have two legacy biotechnology programs that are focused on different diseases or medical conditions, and that target different factors, molecules or proteins. Due to restrictions in the Company’s resources, the Company has slowed down research and development activities significantly in the SCA platform (discussed below) and the anti-TNF platform (discussed below), and the Company as discussed below, the Company’s license agreement relating to the α7nAChR platform (discussed below) was terminated in November 2024. The Company is currently evaluating all options to monetize its existing life science assets, in addition to exploring other strategic alternatives to maximize value for its stockholders. Our legacy biotechnology programs include: fibrosis and anti-tumor necrosis factor (“TNF”); and drugs which are derivatives of cannabidiol (“CBD”) or cannabigerol (“CBG”) analogues (“SCAs”) The license agreement with Stanford University covering α7nAChR was terminated effective November 23, 2024. After a careful review of the Company’s intellectual property portfolio as part of the Company’s ongoing strategic review process, the Company decided to move in a different direction and returned the intellectual property to Stanford University. The 10Q also discusses the online casino business, noting that: On September 29, 2024, we entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Elray Resources, Inc. (“Elray”). Pursuant to the Purchase Agreement, Elray agreed to sell us certain source code and intellectual property relating to an online blockchain casino (the “Purchased Assets”) in consideration for 1,000,000 shares of then newly designated Series B Convertible Preferred Stock (the “Preferred Stock”) and warrants to purchase 3,000,000 shares of common stock of the Company (the “Purchase Warrants”). The fact that these shares appear to have been repurchased, potentially suggests that 180 entered the online casino business and exited it in within a matter of months, having opted to go in a different direction, i.e., into the Ethereum treasury business. In fact, in its late July press release 180 notes that there were "over 60 institutional and crypto-native investors in the PIPE transaction," that "Electric Capital will serve as the external asset manager for the Company, and plans to implement a differentiated, on-chain yield generation program," and finally, that: The Company expects to be positioned to deliver immediate value to shareholders upon the close of this transaction, and through the execution of its long-term investment strategy to acquire ETH and generate yield using the Company's ETH treasury. The Company plans to launch with a key partner in Etherealize. Etherealize brings key strategic partnerships with current leaders in the Ethereum ecosystem which may provide ongoing marketing and amplification value to the Company's Treasury Strategy. Latest Developments - Convertible Notes Issued, Peter Thiel Invests? Earlier today, 180 announced that it has a total holding of: 82,186 Ether ("ETH") at an average acquisition price of $3,806.71, which is now valued at approximately $349 million. In addition to the ETH, ETHZilla holds approximately $238 million in USD cash equivalents. 180 - or to refer to the company under its new name - ETHZilla - now has a market cap valuation of $1.3bn, and climbing - a pretty impressive turnaround for a biotech that could only attract 9 people to a clinical study a couple of years ago. McAndrew Rudisil, who has indeed become Executive Chairman of the Company, commented that: we believe that this reserve of ETH will unlock cash flow for our shareholders as we seek to deliver on our on-chain yield generation program through our external asset manager Electric Capital The press release added that: The Company will continue to provide updates to its Treasury and on chain yield generation strategies, through public releases and regulatory filing(s), as available. Whether there are any shareholders left who still believed they were invested in a struggling biotech company is open to debate, but if there are, they perhaps may have thought the FDA had suddenly opted to approved adalumimab for Dupuytren’s Contracture after all - they will certainly be in for a surprise today! Seemingly, some of today's gains are related to the fact that renowned Silicon Valley investor Peter Thiel has acquired a 7.5% stake in the business. Yesterday, the company announced the "closing of a private offering of approximately $156m of convertible notes." What will the company use the fresh funds for? You guessed it, "primarily to rapidly increase its ETH holdings." At the end of the release, in the "About 180 Life Sciences" section, it's noted: The Company is an innovative biotechnology company that has been evolving its business towards software enabled gaming and entertainment. In addition to its existing biotech assets, 180 Life Sciences continues to maintain and accelerate the deployment and development of its gaming initiatives. The Company plans to rebrand as ETHZilla Corporation. By integrating a pioneering ETH treasury strategy, the Company seeks to become a benchmark for onchain treasury management among public companies. Analysis - A Pivot This Quick & Dramatic Feels New - Although I can Think Of Two Further Examples What strikes me as odd - although I am not particularly experienced in terms of how these things work - is that at no point have shareholders been asked to vote on the company's pivot into becoming an Ethereum treasury, or indeed into an online gaming platform. Perhaps shareholders won't care about that now, because the failing company they were invested in has become a sensational bull story. According to MarketBeat, only 1.9% of 180's share float was held short as of July 15th, although that percentage may well have changed, as the share price volatility is not dissimilar to the meme stock "short squeezes" made famous by the likes of, e.g., GameStop ( GME ) and the Robinhood (HOOD) investment platform. Interestingly, this is the third "biotech" (I am using the term somewhat loosely here) to pivot into blockchain management. One of the others is Upexi ( UPXI ). Upexi describes itself (on its website ) as: a new institutional gateway to Solana’s speed, scale, and rapidly expanding ecosystem. We are the leading Solana-focused treasury company, purpose-built to help institutions capture upside in the most performant blockchain network in crypto. Backed by 15 of the most prestigious digital asset venture capital firms, we’re unlocking access to programmable capital and real-time market infrastructure – without the operational complexity. Upexi accumulates locked SOL at a discount, creating built-in gains for shareholders. We then stake this SOL to earn a 7–9% yield, turning the treasury into a productive asset. Upexi (just about) qualifies as a biotech stock thanks to a suite of products it sells, e.g., "Cure Mushrooms," and "Prax," "the highest quality mushroom extracts in tinctures and gummies." Upexi has been a CBD distributor known as Grow Inc, and an e-commerce brand owner for health and wellness products in previous incarnations, as was known as "Grove" when it completed an initial public offering in 2021 raising $11m at $5 per share. Additionally, Semler Scientific (SMLR) is an unusual medical device company - according to its Q3 2024 quarterly report / 10Q submission : Our patented and FDA cleared product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of cardiovascular diseases, such as peripheral arterial disease, or PAD. We also invest in bitcoin and have adopted bitcoin as our primary treasury asset. In Semler's Q2 2025 earning press release , Eric Semler , executive chairman of Semler Scientific states: "We purchased approximately $195.4 million of Bitcoin since the first quarter, bringing the value of our total holdings to nearly $586.2 million as of July 31, 2025. Year-to-date through July 31, 2025, this strategy has generated more than $110.4 million in unrealized gains and delivered a 31.3% Concluding Thoughts - Is Blockchain the New Biotech? No, But Quick Access To Stock Markets Is Invaluable For Some I am speculating somewhat, as I generally cover biotech stocks and am less familiar with blockchain, and cryptocurrencies (although I have spent time consulting on them in the past). However, presumably if a blockchain / cryptocurrency treasury operator, buyer, or speculator wants to gain access to the public markets, it may take years to prepare the necessary legal documents, appoint the right oversight teams, etc. and so on. Perhaps assuming control of a company flirting with delisting due to fatal business flaws (in 180's case, its failure to progress its pipeline and exhausted funds) would be a much faster, and potentially cheaper way to gain access to better funding opportunities? If the result of such actions is a share price that grows nearly 400% in value in less than one year, shareholders are unlikely to object. As such, will we see three biotechs pivoting into cryptocurrency become 10, 20, or >100 in the next few years? After all, by my count, there are >300 biotechs with a market cap valuation It's a fascinating new dynamic to contemplate, although I highly doubt the trickle could possibly become a flood. I'd be interested to know what readers think, but for now, 180 or rather ETHZilla shareholders can be delighted with today's gains, and may be inclined to sell before a massive drop, or remain invested, awaiting even higher prices. It may be worth noting that Upexi stock is up 75% year-to-date, and that Semler stock is up a comparatively modest 25% on a 12-month basis.
A notable shift in Ripple’s stablecoin operations has been observed on-chain, with 20,000,000 RLUSD burned on Ethereum and an identical amount minted on the XRP Ledger (XRPL). The development, highlighted by blockchain analyst Vet via the Ripple Stablecoin Tracker on X, signals a strategic redistribution of RLUSD supply between the two supported networks. On-Chain Activity Confirms the Movement According to the Ripple Stablecoin Tracker feed, the RLUSD Treasury executed two significant transactions within minutes of each other. On Ethereum, 20 million RLUSD were permanently removed from circulation through a burn transaction, as verified by Etherscan records. Almost simultaneously, XRPSCAN data showed a fresh issuance of the same amount on the XRP Ledger. This mirrored activity suggests an intentional reallocation of RLUSD liquidity, shifting stablecoin reserves away from Ethereum’s ERC-20 format and into XRPL’s native token infrastructure. Looks like $RLUSD contingent is moved from ETH to the XRP Ledger. Call it, The Rotation. pic.twitter.com/kaNITxxNkj — Vet (@Vet_X0) August 11, 2025 Background on RLUSD RLUSD, Ripple’s U.S. dollar-backed stablecoin , launched in December 2024 with deployments on both Ethereum and the XRP Ledger. The stablecoin was designed to leverage the settlement capabilities of XRPL while also offering compatibility with Ethereum’s expansive DeFi ecosystem. Ripple retains full control over minting and burning RLUSD on both blockchains, enabling the company to manage the circulating supply dynamically across networks. Since its launch, RLUSD has seen growing transactional momentum on XRPL, driven by lower fees, faster settlement times, and native integration with Ripple-powered payment solutions. The latest movement aligns with this growing XRPL-centric activity, potentially enhancing liquidity where demand is strongest. Operational Implications Redistributing stablecoin supply between chains is a standard treasury management practice for centralized issuers. By burning RLUSD on Ethereum and minting the equivalent amount on XRPL, Ripple can optimize liquidity for specific markets, reduce operational costs, and better position the stablecoin for active use in XRPL-based applications. We are on twitter, follow us to connect with us :- @TimesTabloid1 — TimesTabloid (@TimesTabloid1) July 15, 2023 While the on-chain evidence documents the transaction flow, Ripple has not issued a formal statement detailing the strategic intent behind this specific adjustment. Without official commentary, the shift can only be interpreted as a deliberate liquidity rebalancing rather than a permanent withdrawal from Ethereum. Strategic Significance For XRP Ledger participants, the additional RLUSD liquidity could improve depth in trading pairs, enhance payment settlement efficiency, and further integrate RLUSD into XRPL-native financial products. For Ethereum users, the burn represents a modest reduction in RLUSD availability, though the stablecoin remains supported on the network. Vet’s timely detection of the movement underscores the growing role of independent blockchain trackers in providing transparency around issuer-controlled digital assets. These observations offer valuable insight into the operational strategies of major stablecoin providers like Ripple. Outlook The 20 million RLUSD reallocation marks one of the largest single supply adjustments since the stablecoin’s launch. If XRPL adoption trends continue, further shifts of this nature could follow, reinforcing XRPL’s position as the primary venue for RLUSD liquidity. Until Ripple provides official confirmation, the move stands as a clear operational rotation — one that may have lasting implications for RLUSD’s on-ledger ecosystem. Disclaimer : This content is meant to inform and should not be considered financial advice. The views expressed in this article may include the author’s personal opinions and do not represent Times Tabloid’s opinion. Readers are urged to do in-depth research before making any investment decisions. Any action taken by the reader is strictly at their own risk. Times Tabloid is not responsible for any financial losses. Follow us on Twitter , Facebook , Telegram , and Google News The post Ripple’s RLUSD Contingent Is Moved from Ethereum to the XRP Ledger appeared first on Times Tabloid .
CryptoAppsy offers real-time crypto data without requiring account registration. Smart alerts and expert news provide timely market insights and opportunities. Continue Reading: Boost Your Crypto Trading with CryptoAppsy’s Smart Features The post Boost Your Crypto Trading with CryptoAppsy’s Smart Features appeared first on COINTURK NEWS .
Terraform Labs co-founder Do Kwon pleaded guilty in a US fraud case related to the $40 billion TerraUSD stablecoin crash in 2022. At a hearing in New York today, Kwon pleaded guilty to conspiracy and wire fraud charges in a deal with prosecutors. Appearing in court in his yellow prison uniform, he also agreed to pay a $19.3 million fine and forfeit some of his assets. “I conspired with others to defraud buyers of cryptocurrencies issued by Terraform Labs, and I did so knowingly. This was wrong, and I apologize for my actions. I accept full responsibility,” he said. Related News: Trump May Announce a New Candidate for FED Chair: Here Are His Views on Cryptocurrency Kwon, who was also indicted in the US and South Korea, played a key role in the crisis that began with the collapse of TerraUSD, leading to major fluctuations in the crypto market in the spring of 2022 and the bankruptcy of the FTX exchange. Under the agreement reached with prosecutors, Kwon faces up to 12 years in prison if he doesn't commit any new crimes. Under normal circumstances, the charges carry a total sentence of up to 25 years. Kwon was indicted in the US in 2023, captured in Montenegro with a fake passport after nearly two years on the run, and extradited to the US in January after being sentenced. This development allowed the case to be concluded early, foregoing a trial scheduled for next year. *This is not investment advice. Continue Reading: Terra (LUNA) Founder Do Kwon’s Prison Sentence Has Been Determined
According to breaking news, Coinbase has added WalletConnect Token (WCT) to its listing roadmap. *This is not investment advice. Continue Reading: BREAKING: Coinbase Announces Listing Amid Rally – Adds to Roadmap
ProPhase Labs is exploring a reverse merger with a digital asset-focused firm and plans to integrate Bitcoin into its reserves to enhance shareholder value. ProPhase Labs’ stock surged over 35%
Bitcoin’s famously noted four-year cycle, previously tied to its halving occurrences, could be losing prime market driver status, according to some top experts. For decades, the halving—a built-in reduction of miner compensation every four years—had been preceded by sharp spikes and precipitous drops in price. Related Reading: Chainlink Tipped To Outshine XRP In Global Banking Links: Analyst Now, however, the market is more subject to the influence of institutional money, regulated investment products, and general economic forces. Halving’s Control Fades As Rivals Gain Strength Pierre Rochard, CEO of The Bitcoin Bond Company, noted the halving’s supply shock is much lower now compared to Bitcoin’s early days, where the majority of the coins were still being mined. Back then, cutting rewards had a clear and heavy impact on the market. In April 2024, Bitcoin’s price pattern broke from tradition. It seems more likely than not that the 4 year cycles are over. Halvings are immaterial to trading float, 95% of the BTC have been mined, supply comes from buying out OGs, demand is the sum of spot retail, ETPs getting added to wealth platforms, and treasury companies. — Pierre Rochard (@BitcoinPierre) August 11, 2025 It had already hit a record above $74,000 in March—weeks before the halving—helped by the US approval of spot Bitcoin ETFs and a wave of institutional buying. Others are of the belief the halving still has a role to play, but no longer determines the price of Bitcoin. They talk about the increased importance of liquidity, ETF trades, and sentiment among investors and they point out these now carry the same weight as supply reductions. Halving’s Role Shrinks As Market Hits Record Highs Others feel the event is still relevant to miner economics and the long-term shortage narrative but has lost some of its power in influencing short-term pricing. To them, halving is simply an element of a larger picture involving macroeconomic trends and foreign capital inflows. Figures published by CoinMarketCap indicate that the combined cryptocurrency market capitalization hit a record high of $4.15 trillion, breaking its previous record of $3.80 trillion. Trading has seen increased levels of action, with over $140 billion of cryptocurrency exchanged in the last day. Related Reading: Ethereum Faith Fading? Samson Mow Says Holders Will Shift To Bitcoin Some observers are warning against writing off the four-year cycle as dead at this time. Excessive optimism often appears near market peaks, when many traders over-extend themselves and end up taking losses. Others went even further and claimed the cycle was never a law of nature but a consequence of the original design of Bitcoin, controlled by retail investors. In the meantime, the four-year cycle may be complete, according to Rochard, as halvings have little impact with 95% of BTC mined and retail, ETPs, and corporate treasuries leading demand. Featured image from Meta, chart from TradingView
Assessing if strong hands can beat Bitcoin's profit panic?